Viking Therapeutics, Inc. (VKTX)

CIK 1607678 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Viking Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 202640002144542-26-000004
Aug 7, 202630002144542-26-000003
Jul 30, 2026S-3ASR0001193125-26-324455
Jul 29, 20268-K0001193125-26-323652
Jul 29, 202640001193125-26-324448
Jul 29, 202610-Q0001193125-26-324219
Jul 29, 20261440001950047-26-007380
Jul 29, 20261440001950047-26-007376
Jul 29, 20261440001950047-26-007394
Jul 29, 202640001193125-26-324446
Jul 29, 202640001193125-26-324447
Jun 3, 202630001193125-26-256038
Jun 3, 202640001193125-26-256039
May 26, 20268-K0001193125-26-239535
Apr 30, 202610-Q0001193125-26-193315
Apr 30, 2026SCHEDULE 13G0002100119-26-001179
Apr 29, 20268-K0001193125-26-191487
Apr 1, 2026DEFA14A0001193125-26-137924
Apr 1, 2026DEF 14A0001193125-26-137915
Apr 1, 2026ARS0001193125-26-137931
Mar 27, 2026SCHEDULE 13G/A0000102909-26-002541
Mar 10, 202640001193125-26-100581
Feb 11, 202610-K0001193125-26-046876
Feb 11, 20268-K0001193125-26-046536
Jan 26, 202630001193125-26-023025